Cargando…

1044. Aztreonam (AZT) vs. Cephalosporin (CEP) Therapy for the Treatment of Gram-Negative Bacteremia

BACKGROUND: The IDSA recommends use of AZT in patients with a confirmed beta-lactam allergy for nosocomial Gram-negative infections. Despite this recommendation, there is limited data to suggest AZT is inferior to cephalosporins (CEP) for the treatment of Gram-negative infections. This study aims to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Sunish, Krevolin, Kyle, Bias, Tiffany
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254044/ http://dx.doi.org/10.1093/ofid/ofy210.881

Ejemplares similares

Risk for primary cephalosporin resistance in Gram-negative bacteremia
por: John, Princy, et al.
Publicado: (2023)

1422. Comparative Monte-Carlo Analysis of Aztreonam-Avibactam vs. Ceftazidime–Avibactam Against Carbapenem-Resistant Gram-Negative Pathogens
por: Smith, Aaron, et al.
Publicado: (2018)

149. Short vs. Long Course of Antibiotics for Uncomplicated Gram-Negative Bacteremia
por: Go, James, et al.
Publicado: (2019)

Activity of Ceftolozane/tazobactam (C/T) and Ceftazidime/avibactam (CZA) against Extended-spectrum Β-lactamase (ESBL)-producing Enterobacteriaceae and Multidrug-resistant (MDR) Pseudomonas aeruginosa Isolates
por: Hirsch, Elizabeth B, et al.
Publicado: (2017)

In Vitro Susceptibility of Aztreonam-Vaborbactam, Aztreonam-Relebactam and Aztreonam-Avibactam Associations against Metallo-β-Lactamase-Producing Gram-Negative Bacteria
por: Emeraud, Cécile, et al.
Publicado: (2023)

1285. Outcomes in Patients with Gram-Negative Bacteremia from Phase 2 and Phase 3 Clinical Trials of Cefiderocol, a Novel Siderophore Cephalosporin
por: Kinoshita, David PatersonDavid PatersonMasahiro, et al.
Publicado: (2020)

Carbapenem vs. Piperacillin-tazobactam for the Treatment of Ceftriaxone-Resistant Gram-Negative Bacteremia: Matched Cohorts by Propensity Score
por: Rajagopal, Sumanth, et al.
Publicado: (2017)

1797. Evaluation of Intravenous vs Oral Antibiotic Therapy at Discharge for the Treatment of Urinary Source Gram-Negative Bacteremia
por: Yan, Xuping, et al.
Publicado: (2022)

219. Clinical Outcomes of Early vs Late Oral Stepdown Therapy in the Management of Uncomplicated Gram-Negative Bacteremia
por: Michael, Amanda, et al.
Publicado: (2023)

219. Outcomes with Low- vs. High-bioavailability Oral Antibiotics in Treatment of Uncomplicated Gram-Negative Bacteremia
por: Cubillos, Ashley L, et al.
Publicado: (2021)

1044. Impact of Interdisciplinary Rounds on Antimicrobial Use at a Community Hospital
por: Castillo, Emma, et al.
Publicado: (2019)

1278. Testing the Synergistic Effect of Ceftazidime-Avibactam Plus Aztreonam on Metallobetalactamase-Producing Non-Fermenting Gram-negative Bacteria
por: Crouch, Elena M, et al.
Publicado: (2021)

Safety of a Carbapenem Restriction Policy in Patients with Gram-Negative Bacteremia
por: Mani, Nandita S, et al.
Publicado: (2017)

258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)

2443. Searching for the Optimal Treatment Regimen for Metallo-β-Lactamase Producing Enterobacteriaceae: Aztreonam Plus Ceftazidime–Avibactam vs. Aztreonam Plus Meropenem–Vaborbactam
por: Biagi, Mark, et al.
Publicado: (2018)

Selection between aztreonam and cephalosporins for treatment of infections with pseudomonads needs more caution
por: Singh, Bhoj R
Publicado: (2019)

200. Comparison of Clinical Outcomes among Patients Treated with Ceftriaxone 2 Grams versus 1 Gram Daily for Gram-Negative Bacteremia
por: Huynh-Phan, Ricky, et al.
Publicado: (2023)

Impact of Verigene Multiplex PCR for Positive Blood Cultures and Gram-negative Bacteremia
por: Adams, Matthew, et al.
Publicado: (2017)

1039. Surveillance Blood Cultures Associated With Decreased Mortality in Gram-Negative Bacteremia
por: Maskarinec, Stacey A, et al.
Publicado: (2018)

150. Urinary Tract-Associated Gram-Negative Bacteremia: Impact of Treatment Duration
por: Badwal, Jasmin K, et al.
Publicado: (2019)

1686. Bacteremia associated with intravascular catheter colonization with Gram-negative rods in children
por: Hisano, Hina, et al.
Publicado: (2023)

177. Infectious Diseases Consultation Associated with Decreased Mortality in Gram-Negative Bacteremia
por: Bruning, Rebecca, et al.
Publicado: (2023)

252 S-649266, a Novel Siderophore Cephalosporin: In vitro activity against Gram-negative bacteria
por: Tsuji, Masakatsu, et al.
Publicado: (2014)

1545. Gram-Negative Bacteremia in Neutropenic Patients: Risk Factors for Mortality in the Era of Multiresistance
por: Herrera, Fabián, et al.
Publicado: (2018)

188. Which patients with gram-negative bacteremia need follow-up blood cultures?
por: Jung, Jongtak, et al.
Publicado: (2019)

1818. Characteristics Associated with Mortality in Patients with Gram-negative Bacteremia in Intensive Care Units
por: Shukdinas, Alaina, et al.
Publicado: (2022)

231. Blood Neutrophil to Lymphocyte Ratio Is Associated with Mortality And Readmission in Gram Negative Bacteremia
por: Roldgaard, Marcus, et al.
Publicado: (2023)

140. Follow-up Blood Cultures for Gram-Negative Bacteremia among Adults with Cancer
por: Haak, David, et al.
Publicado: (2023)

713 Short vs Long Courses of Antibiotic Treatment in Adults with Uncomplicated Gram-negative Bacteremia in a Tertiary Inistituition
por: Zhou, Yvonne Peijun, et al.
Publicado: (2014)

2278. The Safety of Aztreonam vs. Ceftazidime in Patients with Penicillin Allergy: A Matched Cohort Study
por: Tan, Jun Jie, et al.
Publicado: (2023)

108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
por: Ganapathiraju, Iaswarya, et al.
Publicado: (2020)

714 Gram Negative Bacteremia: Are Shorter Courses of Antimicrobial Therapy Feasible?
por: Swamy, Siddharth, et al.
Publicado: (2014)

271. Clinical Outcomes Treating Gram-Negative Bacteremia with Oral Beta-Lactams vs. Trimethoprim-Sulfamethoxazole or Fluoroquinolone Step-Down Therapy
por: Sinclair, Emily, et al.
Publicado: (2020)

192. Augmenting Utility of Rapid Diagnostic Testing in Treatment of Gram-Negative Bacteremia with Stewardship Intervention
por: Gerges, Jessica, et al.
Publicado: (2019)

519. Multidrug-resistant Gram-Negative Bacteremia in Pediatric Patients: Is It Time to Change to Empiric Meropenem?
por: Mongkolrattanothai, Kanokporn, et al.
Publicado: (2019)

1171. Impact of Catheter Management on the Clinical Outcome in Adult Cancer Patients with Gram-Negative Bacteremia
por: Fares, Johny, et al.
Publicado: (2019)

1782. Antimicrobial Stewardship Opportunities in Gram-Negative Bacteremia Treatment at a Community Teaching Hospital
por: Ficinski, Matthew, et al.
Publicado: (2022)

216. A Comparison of Multidrug-Resistant Gram-negative Bacteremia in Cancer and Non-Cancer Patients
por: Haris Khan, Muhammad, et al.
Publicado: (2023)

244. Predictors and Outcomes of Multi-Drug Resistant Gram-Negative Bacteremia in Patients with Solid Tumours
por: Varghese, George M, et al.
Publicado: (2023)

9. Evaluation of Synergy Testing Methods for Clinical Labs to Determine Susceptibility of Extensively Drug-resistant Gram-negatives to Ceftazidime/ Avibactam and Aztreonam Combination Therapy
por: Khan, Ayesha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bgdt0gek0ggiivnqnfehs2ano5